Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000167218 | SCV000218055 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000231679 | SCV000285927 | likely benign | Familial adenomatous polyposis 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000231679 | SCV000487340 | likely benign | Familial adenomatous polyposis 2 | 2016-03-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001706090 | SCV000526252 | likely benign | not provided | 2021-01-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000167218 | SCV000903448 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000440796 | SCV001361130 | likely benign | not specified | 2019-07-13 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000167218 | SCV002532231 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-26 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000231679 | SCV004826586 | likely benign | Familial adenomatous polyposis 2 | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535136 | SCV004712984 | likely benign | MUTYH-related disorder | 2021-11-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |